Dabigatran and rivaroxaban versus warfarin in patients with high risk of stroke and embolism undergoing electrical cardioversion with persistent and long-acting atrial fibrillation

O Kalejs; A Strelnieks; M Kovalova; I Sime; M Vikmane; S Sakne; I Cgojeva; M Zabunova; A Lejnieks; A Erglis

Dabigatran and rivaroxaban versus warfarin in patients with high risk of stroke and embolism undergoing electrical cardioversion with persistent and long-acting atrial fibrillation

O Kalejs, A Strelnieks, M Kovalova, I Sime, M Vikmane, S Sakne, I Cgojeva, M Zabunova, A Lejnieks, A Erglis

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	378
Number of pages	1
Journal	European Heart Journal
Volume	36
Issue number	Suppl.1
Publication status	Published - 1 Aug 2015
Externally published	Yes
Event	Congress of the European Society of Cardiology (ESC) - London, United Kingdom Duration: 29 Aug 2015 → 2 Sept 2015 https://www.escardio.org/The-ESC/Press-Office/Press-releases/ESC-Congress-2015-programme-online-today

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this

@article{ff8cb212de9c463bb06a360732684e09,

title = "Dabigatran and rivaroxaban versus warfarin in patients with high risk of stroke and embolism undergoing electrical cardioversion with persistent and long-acting atrial fibrillation",

author = "O Kalejs and A Strelnieks and M Kovalova and I Sime and M Vikmane and S Sakne and I Cgojeva and M Zabunova and A Lejnieks and A Erglis",

year = "2015",

month = aug,

day = "1",

language = "English",

volume = "36",

pages = "378",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Suppl.1",

note = "Congress of the European Society of Cardiology (ESC) ; Conference date: 29-08-2015 Through 02-09-2015",

url = "https://www.escardio.org/The-ESC/Press-Office/Press-releases/ESC-Congress-2015-programme-online-today",

}

Dabigatran and rivaroxaban versus warfarin in patients with high risk of stroke and embolism undergoing electrical cardioversion with persistent and long-acting atrial fibrillation. / Kalejs, O ; Strelnieks, A; Kovalova, M et al.
In: European Heart Journal, Vol. 36, No. Suppl.1, 01.08.2015, p. 378.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Dabigatran and rivaroxaban versus warfarin in patients with high risk of stroke and embolism undergoing electrical cardioversion with persistent and long-acting atrial fibrillation

AU - Kalejs, O

AU - Strelnieks, A

AU - Kovalova, M

AU - Sime, I

AU - Vikmane, M

AU - Sakne, S

AU - Cgojeva, I

AU - Zabunova, M

AU - Lejnieks, A

AU - Erglis, A

PY - 2015/8/1

Y1 - 2015/8/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:000361205103148&DestLinkType=FullRecord&DestApp=WOS

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000361205103148

M3 - Meeting Abstract

SN - 0195-668X

VL - 36

SP - 378

JO - European Heart Journal

JF - European Heart Journal

IS - Suppl.1

T2 - Congress of the European Society of Cardiology (ESC)

Y2 - 29 August 2015 through 2 September 2015

ER -

Dabigatran and rivaroxaban versus warfarin in patients with high risk of stroke and embolism undergoing electrical cardioversion with persistent and long-acting atrial fibrillation

Field of Science*

Publication Type*

Other files and links

Cite this